Introduction:
The pharmaceutical industry in South Korea has been experiencing significant growth in recent years, with a focus on biologic manufacturing. With advancements in technology and research, South Korea has become a key player in the global biologic market. In 2025, South Korea’s biologic exports reached a record high of $5.6 billion, showcasing the country’s expertise in this sector.
Top 30 Premier Biologic Manufacturers in South Korea 2026:
1. Samsung Biologics
– Leading the pack is Samsung Biologics, with a production volume of over 400,000 liters in 2026. The company’s state-of-the-art facilities and cutting-edge technology have solidified its position as a premier biologic manufacturer in South Korea.
2. Celltrion
– Celltrion is another key player in the South Korean biologic market, with a market share of 20% in 2026. The company’s innovative research and development initiatives have led to the production of high-quality biologics that cater to various medical needs.
3. LG Chem
– LG Chem has emerged as a top biologic manufacturer in South Korea, with exports reaching $1.2 billion in 2026. The company’s commitment to quality and efficiency has made it a preferred choice among healthcare providers worldwide.
4. Hanmi Pharmaceutical
– Hanmi Pharmaceutical has made significant strides in the biologic sector, with a production volume of 150,000 liters in 2026. The company’s focus on research and development has resulted in the creation of cutting-edge biologics that address unmet medical needs.
5. GC Pharma
– GC Pharma is a leading biologic manufacturer in South Korea, with a market share of 15% in 2026. The company’s dedication to innovation and quality has positioned it as a key player in the global biologic market.
6. SK Biopharmaceuticals
– SK Biopharmaceuticals has established itself as a premier biologic manufacturer in South Korea, with exports totaling $800 million in 2026. The company’s commitment to research and development has led to the production of innovative biologics that improve patient outcomes.
Insights:
The future of the biologic manufacturing industry in South Korea looks promising, with a projected growth rate of 10% annually. The increasing demand for biologics, coupled with advancements in technology, is expected to drive further innovation and expansion in the sector. South Korea’s strategic location in Asia and its strong regulatory framework make it an attractive destination for biologic manufacturers looking to tap into the growing market. As the country continues to invest in research and development, we can expect to see more South Korean companies emerge as top players in the global biologic market.
Related Analysis: View Previous Industry Report
